We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
INTERLEUKIN-38 (IL-38) IS A NOVEL BIOCHEMICAL MARKER IN SERA OF IRAQI PATIENTS WITH ALZHEIMERS DISEASE.
- Authors
Yahya, Ayat Mahmood; Jasim, Rasha Zuhair
- Abstract
Alzheimer’s disease (AD) is one of the most common inflammatory neurodegenerative diseases linked with dementia, it is characterized by the deposition of amyloid beta-peptide (Aβ) in the brain. The present study aims to innovate a biochemical relationship between AD and interleukin 38 (IL-38) as an anti-inflammatory cytokine, expose novel mechanisms and concepts regarding other biochemical parameters studied previously or recently in AD patients and also examine the biochemical action of memantine (10 mg daily) on AD patients. Sixty (60) diagnosed AD patients participated in the present study and classified into four (4) groups: G3 were composed of (15) newly diagnosed males (52-78) years / without treatment, G4 composed of (15) newly diagnosed females (64-90) years/ without treatment, G5 composed of (15) males (60-85) years / under treatment with memantine and G6 composed of (15) females (65-73) years also under treatment with memantine. Patients were compared with healthy subjects as two control groups: G1 composed of (15) males /(52-80) years and G2 composed of (15) females / (64-82) years. Blood samples were collected from the patients and control subjects from November 20th, 2019 to February 26th, 2020. The biochemical parameters determined in the sera of all groups are Interleukin 38, ornithine, and TSH. Results of the present study have revealed that IL-38 level was highly significantly increased in G3 and G4 compared with G1 and G2 respectively while it was highly significant increased in G5 compared with G3 and non significantly increased in G6 compared with G4, the difference between (G5 and G1) and between (G6 and G2) was highly significant while the difference between G4 and G3 was nonsignificant. Ornithine level was highly significantly increased in G3 and G4 compared with G1 and G2 respectively, while it was non significantly decreased in G5 and G6 compared with G3 and G4, respectively. The difference between (G5 and G1) and between (G6 and G2) was highly significant while it was non-significant between G4 and G3. TSH level was highly significant decreased in G3 compared with G1, while it was non significantly decreased in G4 compared with G2. However, it was highly significantly increased in G5 and G6 compared with G3 and G4, respectively, the difference between (G5 and G1) and between (G4 and G3) was nonsignificant while, it was highly significant between (G6 and G2). The present study is the first to report that IL-38 is a novel biochemical marker for AD and also the first elucidating the biochemical action of memantine on IL-38 (by highlighting the anti-inflammatory responses) and ornithine based on the reversible biochemical relationship between arginine, ornithine and glutamate.
- Subjects
ALZHEIMER'S disease; INTERLEUKINS; BIOMARKERS; NEURODEGENERATION; GLUTAMIC acid
- Publication
Biochemical & Cellular Archives, 2021, Vol 21, Issue 1, p1579
- ISSN
0972-5075
- Publication type
Article